Literature DB >> 16967191

Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation.

J B Perz, A V Kristen, A Rahemtulla, J Parameshwar, F-U Sack, J F Apperley, H Goldschmidt, H A Katus, T J Dengler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16967191     DOI： 10.1007/s00392-006-0439-y

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  13 in total

1.  Stem cell transplantation for the management of primary systemic amyloidosis.

Authors:  Morie A Gertz; Martha Q Lacy; Angela Dispenzieri; Dennis A Gastineau; Michael G Chen; Stephen M Ansell; David J Inwards; Ivana N M Micallef; Ayalew Tefferi; Mark R Litzow
Journal:  Am J Med       Date:  2002-11       Impact factor: 4.965

Review 2.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

Review 3.  Autologous stem cell transplantation for primary systemic amyloidosis.

Authors:  Raymond L Comenzo; Morie A Gertz
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

4.  High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.

Authors:  Jolanta B Perz; Stefan O Schonland; Michael Hundemer; Arnt V Kristen; Thomas J Dengler; Martin Zeier; Reinhold P Linke; Anthony D Ho; Hartmut Goldschmidt
Journal:  Br J Haematol       Date:  2004-12       Impact factor: 6.998

5.  Heart transplantation in patients with amyloidosis: single-center experience.

Authors:  A Alloni; C Pellegrini; T Ragni; C Goggi; A M D'Armini; M Rinaldi; M Viganò
Journal:  Transplant Proc       Date:  2004-04       Impact factor: 1.066

6.  Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Follow-up results of a multicenter survey.

Authors:  J D Hosenpud; T DeMarco; O H Frazier; B P Griffith; B F Uretsky; A H Menkis; J B O'Connell; M T Olivari; H A Valantine
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

7.  High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Authors:  Martha Skinner; Vaishali Sanchorawala; David C Seldin; Laura M Dember; Rodney H Falk; John L Berk; Jennifer J Anderson; Carl O'Hara; Kathleen T Finn; Caryn A Libbey; Janice Wiesman; Karen Quillen; Niall Swan; Daniel G Wright
Journal:  Ann Intern Med       Date:  2004-01-20       Impact factor: 25.391

8.  Cardiac transplantation for amyloid heart disease: the United Kingdom experience.

Authors:  Simon W Dubrey; Margaret M Burke; Philip N Hawkins; Nicholas R Banner
Journal:  J Heart Lung Transplant       Date:  2004-10       Impact factor: 10.247

Review 9.  Long-term survival (10 years or more) in 30 patients with primary amyloidosis.

Authors:  R A Kyle; M A Gertz; P R Greipp; T E Witzig; J A Lust; M Q Lacy; T M Therneau
Journal:  Blood       Date:  1999-02-01       Impact factor: 22.113

10.  Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.

Authors:  Julian D Gillmore; Hugh J Goodman; Helen J Lachmann; Mark Offer; Ashutosh D Wechalekar; Jayshree Joshi; Mark B Pepys; Philip N Hawkins
Journal:  Blood       Date:  2005-10-06       Impact factor: 22.113
View more
  4 in total

1.  Therapy effects of green tea in a patient with systemic light-chain amyloidosis.

Authors:  Derliz Mereles; Erich E Wanker; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2008-03-03       Impact factor: 5.460

Review 2.  [Risk stratification and treatment of cardiac amyloidoses].

Authors:  A V Kristen; S O Schönland; A Remppis; U Hegenbart; P A Schnabel; H A Katus; T J Dengler
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

Review 3.  Heart transplantation in cardiac amyloidosis.

Authors:  Matthew Sousa; Gregory Monohan; Navin Rajagopalan; Alla Grigorian; Maya Guglin
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

4.  Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study).

Authors:  T Bartsch; M Brehm; T Zeus; G Kögler; P Wernet; B E Strauer
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.